Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-04-01

Clinical Trial Update: Tramadol/Acetaminophen(Ultracet) AS add-on Therapy in the Treatment of Patients With Ankylosing Spondylitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating tramadol/acetaminophen (Ultracet) as add-on therapy for ankylosing spondylitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ULTRACET (tramadol hydrochloride/acetaminophen)

Snippet

Sponsor: Chung Shan Medical University | Conditions: Ankylosing Spondylitis | Phase 4 | Status: COMPLETED